Get the Stockscreener App
17.57
1.95%
-0.35
After Hours:
17.57
Upstream Bio Inc stock is traded at $17.57, with a volume of 282.43K.
It is down -1.95% in the last 24 hours and up +0.40% over the past month.
Upstream Bio Inc is a clinical-stage biotechnology company developing treatments for inflammatory diseases, with an initial focus on severe respiratory disorders. It is developing verekitug, the known antagonist currently in clinical development that targets the receptor for Thymic Stromal Lymphopoietin (TSLP), a cytokine that is a clinically validated driver of inflammatory response positioned upstream of multiple signaling cascades that affect a variety of immune-mediated diseases.
See More
Previous Close:
$17.92
Open:
$18
24h Volume:
282.43K
Relative Volume:
0.57
Market Cap:
$947.19M
Revenue:
$2.22M
Net Income/Loss:
$-40.51M
P/E Ratio:
-13.68
EPS:
-1.2847
Net Cash Flow:
$-46.53M
1W Performance:
-12.02%
1M Performance:
+0.40%
6M Performance:
+90.36%
1Y Performance:
+0.00%
1-Day Range:
$17.54
$18.11
1-Week Range:
$17.02
$20.32
52-Week Range:
$5.14
$29.46
Upstream Bio Inc Stock (UPB) Company Profile
Name
Upstream Bio Inc
Sector
Industry
Phone
781-208-2466
Address
890 WINTER STREET, SUITE 200, WALTHAM
Compare UPB with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
UPB
Upstream Bio Inc
|
17.57 | 959.59M | 2.22M | -40.51M | -46.53M | -1.2847 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Upstream Bio Inc Stock (UPB) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-05-24 | Initiated | JP Morgan | Overweight |
| Nov-05-24 | Initiated | Piper Sandler | Overweight |
| Nov-05-24 | Initiated | TD Cowen | Buy |
| Nov-05-24 | Initiated | William Blair | Outperform |
Upstream Bio Inc Stock (UPB) Latest News
Is Upstream Bio Inc. stock reversal real or fakeMarket Trend Review & Real-Time Market Sentiment Reports - Newser
Real time alert setup for Upstream Bio Inc. performanceJuly 2025 Breakouts & Precise Trade Entry Recommendations - Newser
Is Upstream Bio Inc. stock poised for growth2025 Trade Ideas & Stock Portfolio Risk Management - Newser
Can Upstream Bio Inc. recover in the next quarterPortfolio Update Report & Weekly Setup with High ROI Potential - Newser
Analyzing drawdowns of Upstream Bio Inc. with statistical toolsQuarterly Performance Summary & Verified Stock Trade Ideas - Newser
Developing predictive dashboards with Upstream Bio Inc. dataTrade Entry Summary & Fast Gain Stock Trading Tips - Newser
How to use Fibonacci retracement on Upstream Bio Inc.Weekly Trend Recap & Free Technical Pattern Based Buy Signals - Newser
Is now a turning point for Upstream Bio Inc.Gold Moves & AI Enhanced Trading Alerts - Newser
Signal strength of Upstream Bio Inc. stock in tech scannersTrade Analysis Summary & Daily Profit Maximizing Tips - Newser
Published on: 2025-09-12 14:03:35 - Newser
What candlestick patterns are forming on Upstream Bio Inc.2025 Key Lessons & Step-by-Step Trade Execution Guides - Newser
Should you hold or exit Upstream Bio Inc. nowDollar Strength & Stepwise Entry and Exit Trade Signals - Newser
Using portfolio simulators with Upstream Bio Inc. included2025 Performance Recap & Technical Entry and Exit Alerts - Newser
What moving averages say about Upstream Bio Inc.2025 Pullback Review & Real-Time Stock Price Movement Reports - Newser
Visual trend scoring systems applied to Upstream Bio Inc.July 2025 Outlook & Short-Term High Return Ideas - Newser
Published on: 2025-09-12 04:27:38 - Newser
Parkman Healthcare Partners LLC Invests $1.43 Million in Upstream Bio, Inc. $UPB - MarketBeat
Is Upstream Bio Inc. forming a bottoming baseMarket Growth Summary & Capital Protection Trading Alerts - Newser
Nuveen LLC Takes $138,000 Position in Upstream Bio, Inc. $UPB - MarketBeat
Is this a good reentry point in Upstream Bio Inc.2025 Volatility Report & Daily Growth Stock Investment Tips - Newser
Advanced analytics toolkit walkthrough for Upstream Bio Inc.July 2025 Review & Expert Approved Momentum Ideas - Newser
Published on: 2025-09-11 02:05:45 - Newser
How to build a dashboard for Upstream Bio Inc. stockTrade Ideas & Scalable Portfolio Growth Methods - Newser
Detecting support and resistance levels for Upstream Bio Inc.2025 Winners & Losers & Low Risk Entry Point Guides - Newser
Has Upstream Bio Inc. formed a bullish divergenceMarket Movers & Safe Entry Point Alerts - Newser
Is Upstream Bio Inc. meeting your algorithmic filter criteriaWeekly Trade Recap & Accurate Trade Setup Notifications - Newser
Upstream Bio to Participate in the Stifel 2025 Virtual Immunology and Inflammation Forum - markets.businessinsider.com
Biotech Startup Upstream Bio Takes Stage at Stifel 2025 Virtual Immunology Forum with CEO Fireside Chat - Stock Titan
Statistical indicators supporting Upstream Bio Inc.’s strengthJuly 2025 Weekly Recap & High Conviction Buy Zone Alerts - Newser
What MACD and RSI say about Upstream Bio Inc.Market Activity Recap & AI Optimized Trade Strategies - Newser
Using fundamentals and technicals on Upstream Bio Inc.2025 AllTime Highs & Safe Capital Growth Trade Ideas - Newser
Long term hold vs stop loss in Upstream Bio Inc.Trade Risk Report & Reliable Entry Point Alerts - Newser
What to expect from Upstream Bio Inc. in the next 30 daysMarket Weekly Review & Reliable Volume Spike Trade Alerts - Newser
Upstream Bio Inc Stock (UPB) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):